CDEK by Data4ThePeople
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
← All indications

Candidiasis, Oral

Infection of the mucous membranes of the mouth by a fungus of the genus CANDIDA. (Dorland, 27th ed)

Drugs by status

Approved for this indication (5)

  • posaconazole
  • miconazole
  • lingonberry nectar
  • hexetidine
  • benzaldehyde

Phase 4 trials (3)

  • fluticasone
  • salmeterol
  • fluconazole

Phase 3 trials (6)

  • urea
  • micafungin
  • gentian violet
  • caspofungin
  • nystatin
  • propolis

Phase 2 trials (4)

  • pac113
  • amphotericin b
  • silver citrate
  • acemannan

Phase 1 trials (2)

  • chitosan
  • nitric oxide

Other trials (9)

  • ozone
  • terbinafine
  • itraconazole
  • ketoconazole
  • hypochlorous acid
  • chlorhexidine
  • Lactobacillus acidophilus
  • glutaraldehyde
  • vacucis autovaccine

Organizations

Organization Involved with Phase 4 Indications (3)

  • National Institute of Allergy and Infectious Diseases (NIAID)
  • Allergy & Asthma Medical Group & Research Center
  • Washington University in St. Louis

Organization Involved with Phase 3 Indications (8)

  • Astellas
  • Boehringer Ingelheim
  • National Cancer Institute (NCI)
  • Centro Universitário
  • University of Malawi
  • University of Sao Paulo
  • Government of Brazil
  • British Society for Antimicrobial Chemotherapy

Organization Involved with Phase 2 Indications (7)

  • Bristol-Myers Squibb
  • Merck
  • Pacgen Biopharmaceuticals Corporation
  • Texas A&M University
  • Hebrew University
  • CelaCare Technologies, Inc.
  • IQVIA

Organization Involved with Other Experimental Indications (5)

  • Pfizer
  • Novartis
  • Summa Health System
  • Yuzuncu Yıl University
  • Procter and Gamble

ICD-10 crosswalk

  • B37.9 — Candidiasis, unspecified

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.